Loading Doses for Recurrent Seizures: Evidence-Based Approach

Indications for Loading Doses

The American College of Emergency Physicians recommends loading doses for patients with refractory status epilepticus who have failed treatment with benzodiazepines 1, 2
Loading doses are appropriate when resuming antiepileptic medication in patients with known seizure disorders who have missed doses or have subtherapeutic levels 3, 4
The mean time to first early seizure recurrence is 121 minutes, with over 85% of early seizures recurring within 360 minutes, supporting the potential need for rapid achievement of therapeutic levels in high-risk patients 5

The American Academy of Neurology recommends oral loading of 20 mg/kg divided in maximum doses of 400 mg every 2 hours for Phenytoin 3, 2
IV loading of 18 mg/kg at maximum rate of 50 mg/minute is recommended for Phenytoin 3
Fosphenytoin IV loading of 18 PE/kg at maximum rate of 150 PE/minute is preferred over IV phenytoin due to fewer adverse events 3, 6
Oral loading of 1,500 mg as a single dose is recommended for Levetiracetam 3, 4
IV loading of up to 30 mg/kg at maximum rate of 10 mg/kg/minute is recommended for Valproate 3, 2
Carbamazepine oral suspension of 8 mg/kg as a single load is recommended 3, 4
Lamotrigine single oral load of 6.5 mg/kg is recommended if previously on lamotrigine for >6 months without history of rash 3, 2
Gabapentin oral loading of 900 mg/day for 3 days is recommended 3, 4

Most studies use serum drug levels as a surrogate outcome measure for efficacy rather than direct measurement of seizure prevention 3, 4
Therapeutic serum phenytoin levels are typically achieved within minutes after IV loading dose completion 6
Oral phenytoin loading takes >5 hours to reach therapeutic levels 3, 2
There is no significant difference in seizure recurrence between oral and IV phenytoin loading, though IV achieves therapeutic levels more quickly 3, 4

Patient-specific risk factors for early seizure recurrence include age ≥40 years, alcoholism, hyperglycemia, and Glasgow Coma Scale score <15 4, 5
Alcoholic patients with a history of seizures have the highest early seizure recurrence rate (25.2%) 5
IV phenytoin carries more serious adverse effects than oral, including hypotension, bradyarrhythmias, cardiac arrest, and extravasation injuries 3, 6

Obtain serum drug concentrations promptly for every antiepileptic drug the patient is receiving to guide dosing decisions in hospitalized individuals with epilepsy. 7

Use fosphenytoin rather than phenytoin because it is associated with fewer cardiovascular adverse events such as hypotension, bradyarrhythmias, and cardiac arrest. 7
Administer fosphenytoin intravenously at 18 PE/kg with a maximum infusion rate of 150 PE/min to rapidly achieve therapeutic levels. 7
An oral loading regimen of phenytoin (20 mg/kg divided into 400 mg doses every 2 hours) requires more than 5 hours to reach therapeutic concentrations, whereas intravenous dosing reaches target levels within minutes; seizure recurrence rates are comparable between routes. 7

Give an intravenous loading dose of valproate at 20–30 mg/kg, not exceeding an infusion rate of 10 mg/kg/min, to quickly attain therapeutic concentrations. 7

Load levetiracetam with 1500 mg either orally or intravenously; doses up to 60 mg/kg IV are safe and well tolerated. 7
Clinical studies report no breakthrough seizures within 24 hours after a loading dose of levetiracetam. 7

Provide a single oral dose of carbamazepine suspension at 8 mg/kg; an intravenous formulation is unavailable, and the suspension offers more reliable absorption than tablets. 7

Load lamotrigine only in patients who have been on the drug for more than 6 months without a rash history and who have been off the medication for fewer than 5 days; the loading dose is 6.5 mg/kg given as a single oral dose. 7
Avoid loading lamotrigine in anyone with a prior rash or who has not previously received the medication because of the risk of serious dermatologic reactions. 7

Prioritize achieving seizure control with a single antiepileptic agent; titrate to the maximum dose the patient can tolerate before considering combination therapy. 8
First‑line monotherapy options include carbamazepine, phenobarbital, phenytoin, and valproic acid. 8
For patients with partial‑onset seizures, carbamazepine is the preferred initial agent. 8
Do not initiate chronic antiepileptic drug therapy after a single unprovoked seizure unless additional risk factors are present. 8